0001109354 false 0001109354 2020-09-03 2020-09-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares






Washington, D.C. 20549





Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): September 3, 2020



(Exact name of registrant as specified in its charter)


Delaware   000-30833   04-3110160
(State or other jurisdiction of   Commission File No.   (I.R.S. Employer
Incorporation or organization)       Identification No.)


40 Manning Road

Billerica, MA 01821

(Address of principal executive offices) (Zip Code)



(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:


¨     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, $0.01 par value per share   BRKR   The Nasdaq Global Select Market


Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company  ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨







Section 5 – Corporate Governance and Management


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(d)            Election of New Director


On September 3, 2020, the Board of Directors (the “Board”) of Bruker Corporation (the “Company”) approved an increase in the number of directors to expand the size of the Board by one director to a total of ten directors, with such additional director assigned to Class I, and appointed Ms. Bonnie H. Anderson to fill the newly-created vacancy on the Board, effective as of September 3, 2020. Ms. Anderson will initially serve as an independent director until the Company’s 2022 Annual Meeting of Stockholders.


Ms. Anderson’s compensation for her services as a director will be consistent with that of the other non-employee directors of the Company, as described in the Company’s definitive proxy statement with respect to its 2020 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on April 22, 2020. There are no other arrangements or understandings between Ms. Anderson and any other person pursuant to which she was appointed as a director, and there are no transactions involving the Company and Ms. Anderson that the Company would be required to report pursuant to Item 404(a) of Regulation S-K.


A copy of the press release announcing Ms. Anderson’s appointment is attached to this report as Exhibit 99.1.


Section 9 – Financial Statements and Exhibits


Item 9.01. Financial Statements and Exhibits.


(d) Exhibits.
  Number   Description
  99.1   Press release dated September 8, 2020.
  104   Cover Page Interactive Data File (embedded within the Inline XBRL document).







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: September 8, 2020 By:   /s/ Gerald N. Herman
    Gerald N. Herman
    Chief Financial Officer